10295520 · Active · incorporated 10 years, 3 months ago · London
Biotech Biotech & Life Sciences Drug Discovery Series B+
Epsilogen is a clinical-stage biotechnology company developing novel antibody therapeutics for oncology.
Epsilogen Ltd is a private limited company registered at Companies House under number 10295520, incorporated on 26 July 2016, with a registered office in London. Its current status on the register is active. Its filed nature of business is other research and experimental development on natural sciences and engineering (SIC 72190). Sonde has indexed 107 filings for this company, including 7 funding rounds. Its most recent round closed in August 2025, raising £39.2m.
| Round | Closed | Raised | Price per share |
|---|---|---|---|
| Round 7 | Aug 2025 | £39.2m | £0.8291 |
| Round 6 | Sep 2024 | £12.5m | £0.8291 |
| Round 5 | Dec 2023 | £5m | £0.83 |
| Round 4 | Feb 2022 | £17m | £0.83 |
| Round 3 | Mar 2020 | £3.1m | £0.55 |
| Round 2 | Nov 2018 | £3m | £0.50 |
Showing the 6 most recent of 7 rounds.
Showing the 10 most recent of 107 filings.
See the complete cap table with every shareholder, founder tags, dilution across 21 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.